Detalhe da pesquisa
1.
Role of epigenetic regulatory mechanisms in age-related bone homeostasis imbalance.
FASEB J;
38(9): e23642, 2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38690719
2.
Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.
J Cell Mol Med;
28(8): e18227, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38520207
3.
Direct Synthesis of α-Ketothioamide Derivatives through a One-Pot Reaction of Sulfur Ylides, Nitrosobenzenes, and Thioacetic Acid.
J Org Chem;
2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38845522
4.
Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins.
Bioorg Chem;
145: 107217, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38368657
5.
Full life cycle changes of low impacted mandibular third molar associated cystic lesions and adjacent tooth root resorption: a retrospective study.
BMC Oral Health;
24(1): 515, 2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38698359
6.
Direct Access to 3-Thioether-Substituted Dihydrofuro[2,3-b]benzofurans via Tandem Reactions of Sulfur Ylides and 2-Nitrobenzofurans.
J Org Chem;
88(15): 10810-10817, 2023 Aug 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37463066
7.
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer.
Bioorg Med Chem;
91: 117384, 2023 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37356356
8.
Recent advances and future perspectives of noncompetitive proteasome inhibitors.
Bioorg Chem;
135: 106507, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37030106
9.
Exploration of novel four-membered-heterocycle constructed peptidyl proteasome inhibitors with improved metabolic stability for cancer treatment.
Bioorg Chem;
138: 106626, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37295239
10.
Exploration of novel dihydroquinoxalinone derivatives as EGFRL858R/T790M tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.
Bioorg Chem;
135: 106494, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37011522
11.
Design of Multi-User Noncoherent Massive SIMO Systems for Scalable URLLC.
Entropy (Basel);
25(9)2023 Sep 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37761624
12.
Design, synthesis and biological evaluation of novel tumor hypoxia-activated EGFR tyrosine kinase inhibitors.
Bioorg Chem;
129: 106138, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36115310
13.
Enhanced anticancer activity by the combination of vinpocetine and sorafenib via PI3K/AKT/GSK-3ß signaling axis in hepatocellular carcinoma cells.
Anticancer Drugs;
32(7): 727-733, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33735117
14.
(2 + 1 + 1 + 1)-Annulation Reactions of Aryldiazonium Tetrafluoroborates with Sulfur Ylides to Polysubstituted Pyrazoles.
J Org Chem;
2021 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34132524
15.
Optimization of piperidine constructed peptidyl derivatives as proteasome inhibitors.
Bioorg Med Chem;
29: 115867, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33223460
16.
The efficacy and safety of cold atmospheric plasma as a novel therapy for diabetic wound in vitro and in vivo.
Int Wound J;
17(3): 851-863, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32168435
17.
Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells.
Biochem Biophys Res Commun;
512(4): 852-858, 2019 05 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30929918
18.
Design, synthesis, and biological evaluation of novel 3-(thiophen-2-ylthio)pyridine derivatives as potential multitarget anticancer agents.
Arch Pharm (Weinheim);
352(8): e1900024, 2019 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31338897
19.
[Research progress on selective immunoproteasome inhibitors].
Zhejiang Da Xue Xue Bao Yi Xue Ban;
48(6): 688-694, 2019 12 25.
Artigo
em Zh
| MEDLINE
| ID: mdl-31955545
20.
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors.
Bioorg Med Chem;
25(12): 3195-3205, 2017 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28412159